Complement therapeutic strategies in trauma, hemorrhagic shock and systemic inflammation – closing Pandora's box?

Seminars in Immunology

Volumn 28, Issue 3, 2016, Pages 278-284

  Huber Lang, Markus ^a   Gebhard, Florian ^a   Schmidt, Christoph Q ^b   Palmer, Annette ^a   Denk, Stephanie ^a   Wiegner, Rebecca ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

C3; C5a; Complement; Hemorrhagic shock; SIRS; Trauma

Indexed keywords

COMPLEMENT; COMPLEMENT INHIBITOR; PATHOGEN ASSOCIATED MOLECULAR PATTERN;

COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; HEMORRHAGIC SHOCK; HUMAN; INFLAMMATION; INJURY; INTERVENTION STUDY; NONHUMAN; PIG; REVIEW; SIMIAN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; DISEASE MODEL; IMMUNOLOGY; IMMUNOTHERAPY; INNATE IMMUNITY; KNOCKOUT MOUSE; MOUSE; PROCEDURES;

ANIMALS; COMPLEMENT INACTIVATING AGENTS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; INFLAMMATION; MICE; MICE, KNOCKOUT; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; SHOCK, HEMORRHAGIC; WOUNDS AND INJURIES;

EID: 84964905464     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2016.04.005     Document Type: Review

References (82)

1. [1] Matzinger, P., The danger model: a renewed sense of self. Science 296 (2002), 301–305.
2. [2] Gebhard, F., Pfetsch, H., Steinbach, G., et al. Is interleukin 6 an early marker of injury severity following major trauma in humans?. Arch. Surg. 135 (2000), 291–295.
3. [3] Keel, M., Trentz, O., Pathophysiology of polytrauma. Injury 36 (2005), 691–709.
4. [4] R.C. Bone, R.A. Balk, F.B. Cerra et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992, Chest 136 (2009) e28.
5. [5] Amara, U., Flierl, M.A., Rittirsch, D., et al. Molecular intercommunication between the complement and coagulation systems. J. Immunol 185 (2010), 5628–5636.
6. [6] Huber-Lang, M., Sarma, J.V., Zetoune, F.S., et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12 (2006), 682–687.
7. [7] Gebhard, F., Huber-Lang, M., Polytrauma–pathophysiology and management principles. Langenbecks Arch. Surg. 393 (2008), 825–831.
8. [8] Frith, D., Goslings, J.C., Gaarder, C., et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J. Thromb. Haemost. 8 (2010), 1919–1925.
9. [9] Balvers, K., Wirtz, M.R., van, D.S., Goslings, J.C., Juffermans, N.P., Risk factors for trauma-induced coagulopathy- and transfusion-associated multiple organ failure in severely injured trauma patients. Front. Med. (Lausanne), 2, 2015, 24.
10. [10] Burk, A.M., Martin, M., Flierl, M.A., et al. Early complementopathy after multiple injuries in humans. Shock 37 (2012), 348–354.
11. [11] Ehrnthaller, C., Amara, U., Weckbach, S., et al. Alteration of complement hemolytic activity in different trauma and sepsis models. J. Inflamm. Res. 5 (2012), 59–66.
12. [12] Huber-Lang, M., Ignatius, A., Brenner, R.E., Role of complement on broken surfaces after trauma. Adv. Exp. Med. Biol. 865 (2015), 43–55.
13. [13] Brinkmann, C.R., Jensen, L., Dagnaes-Hansen, F., et al. Mitochondria and the lectin pathway of complement. J. Biol. Chem. 288 (2013), 8016–8027.
14. [14] Zhang, Q., Raoof, M., Chen, Y., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464 (2010), 104–107.
15. [15] Bjornson, A.B., Altemeier, W.A., Bjornson, H.S., Host defense against opportunist microorganisms following trauma. II. Changes in complement and immunoglobulins in patients with abdominal trauma and in septic patients without trauma. Ann. Surg. 188 (1978), 102–108.
16. [16] Hecke, F., Schmidt, U., Kola, A., et al. Circulating complement proteins in multiple trauma patients–correlation with injury severity, development of sepsis, and outcome. Crit. Care Med. 25 (1997), 2015–2024.
17. [17] Zilow, G., Joka, T., Obertacke, U., Rother, U., Kirschfink, M., Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome. Crit. Care Med. 20 (1992), 468–473.
18. [18] Muroya, T., Kannan, L., Ghiran, I.C., et al. C4d deposits on the surface of RBCs in trauma patients and interferes with their function. Crit. Care Med. 42 (2014), e364–e372.
19. [19] Ganter, M.T., Brohi, K., Cohen, M.J., et al. Role of the alternative pathway in the early complement activation following major trauma. Shock 28 (2007), 29–34.
20. [20] Lampl, L., Seifried, E., Tisch, M., et al. Hemostatic disorders following polytrauma–the role of physiologic coagulation inhibitors during the preclinical phase. Anasthesiol. Intensivmed. Notfallmed. Schmerzther. 27 (1992), 31–36.
21. [21] Kanse, S.M., Gallenmueller, A., Zeerleder, S., et al. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a. J. Immunol 188 (2012), 2858–2865.
22. [22] Kenawy, H.I., Boral, I., Bevington, A., Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH. Front. Immunol., 6, 2015, 215.
23. [23] Fishelson, Z., Horstmann, R.D., Muller-Eberhard, H.J., Regulation of the alternative pathway of complement by pH. J. Immunol 138 (1987), 3392–3395.
24. [24] Fosse, E., Pillgram-Larsen, J., Svennevig, J.L., et al. Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury 29 (1998), 509–514.
25. [25] Frith, D., Davenport, R., Brohi, K., Acute traumatic coagulopathy. Curr. Opin. Anaesthesiol. 25 (2012), 229–234.
26. [26] Amara, U., Kalbitz, M., Perl, M., et al. Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans. Shock 33 (2010), 568–575.
27. [27] Weigelt, J.A., Chenoweth, D.E., Borman, K.R., Norcross, J.F., Complement and the severity of pulmonary failure. J. Trauma 28 (1988), 1013–1019.
28. [28] Lohde, E., Raude, H., Luck, M., Kraas, E., Lierse, W., Complement activated granulocytes can cause autologous tissue destruction in man. Mediators Inflamm. 1 (1992), 177–181.
29. [29] Huber-Lang, M., Sarma, V.J., Lu, K.T., et al. Role of C5a in multiorgan failure during sepsis. J. Immunol. 166 (2001), 1193–1199.
30. [30] Huber-Lang, M.S., Younkin, E.M., Sarma, J.V., et al. Complement-induced impairment of innate immunity during sepsis. J. Immunol. 169 (2002), 3223–3231.
31. [31] Unnewehr, H., Rittirsch, D., Sarma, J.V., et al. Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J. Immunol. 190 (2013), 4215–4225.
32. [32] Huber-Lang, M., Sarma, J.V., Rittirsch, D., et al. Changes in the novel orphan C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J. Immunol. 174 (2005), 1104–1110.
33. [33] MacKenzie, J.A. Jr., Morris, E.J., Edelstein, S.L., The effect of preexisting conditions on mortality in trauma patients. JAMA 263 (1990), 1942–1946.
34. [34] Xu, R., Lin, F., Bao, C., et al. Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis. Cell Mol. Immunol. 13 (2016), 103–109.
35. [35] Neher, M.D., Weckbach, S., Flierl, M.A., Huber-Lang, M.S., Stahel, P.F., Molecular mechanisms of inflammation and tissue injury after major trauma – is complement the bad guy?. J. Biomed. Sci., 18, 2011, 90.
36. [36] Holers, V.M., Thurman, J.M., The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol. Immunol. 41 (2004), 147–152.
37. [37] Kaczorowski, S.L., Schiding, J.K., Toth, C.A., Kochanek, P.M., Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 15 (1995), 860–864.
38. [38] Kulkarni, A.P., Kellaway, L.A., Lahiri, D.K., Kotwal, G.J., Neuroprotection from complement-mediated inflammatory damage. Ann. N. Y. Acad. Sci. 1035 (2004), 147–164.
39. [39] Leinhase, I., Holers, V.M., Thurman, J.M., et al. Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci., 7, 2006, 55.
40. [40] Leinhase, I., Schmidt, O.I., Thurman, J.M., et al. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. Exp. Neurol. 199 (2006), 454–464.
41. [41] Leinhase, I., Rozanski, M., Harhausen, D., et al. Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. J. Neuroinflammation, 4, 2007, 13.
42. [42] Sewell, D.L., Nacewicz, B., Liu, F., et al. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. J. Neuroimmunol. 155 (2004), 55–63.
43. [43] Knoferl, M.W., Liener, U.C., Seitz, D.H., et al. Cardiopulmonary, histological, and inflammatory alterations after lung contusion in a novel mouse model of blunt chest trauma. Shock 19 (2003), 519–525.
44. [44] Recknagel, S., Bindl, R., Kurz, J., et al. Experimental blunt chest trauma impairs fracture healing in rats. J. Orthop. Res. 29 (2011), 734–739.
45. [45] Recknagel, S., Bindl, R., Brochhausen, C., et al. Systemic inflammation induced by a thoracic trauma alters the cellular composition of the early fracture callus. J. Trauma Acute Care Surg. 74 (2013), 531–537.
46. [46] Flierl, M.A., Perl, M., Rittirsch, D., et al. The role of C5a in the innate immune response after experimental blunt chest trauma. Shock 29 (2008), 25–31.
47. [47] Mulligan, M.S., Schmid, E., Beck-Schimmer, B., et al. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98 (1996), 503–512.
48. [48] Bless, N.M., Warner, R.L., Padgaonkar, V.A., et al. Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion. Am. J. Physiol. 276 (1999), L57–L63.
49. [49] Kyriakides, C., Austen, W. Jr., Wang, Y., et al. Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex. Am. J. Physiol. 277 (1999), C1263–C1268.
50. [50] Kyriakides, C., Austen, W.G. Jr., Wang, Y., et al. Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent. J. Trauma 48 (2000), 32–38.
51. [51] Kyriakides, C., Wang, Y., Austen, W.G. Jr., et al. Moderation of skeletal muscle reperfusion injury by a sLe(x)-glycosylated complement inhibitory protein. Am. J. Physiol. Cell Physiol. 281 (2001), C224–C230.
52. [52] Toomayan, G.A., Chen, L.E., Jiang, H.X., et al. C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle. Microsurgery 23 (2003), 561–567.
53. [53] Woodruff, T.M., Arumugam, T.V., Shiels, I.A., et al. Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J. Surg. Res. 116 (2004), 81–90.
54. [54] Younger, J.G., Sasaki, N., Delgado, J., et al. Systemic and lung physiological changes in rats after intravascular activation of complement. J. Appl. Physiol. (1985) 90 (2001), 2289–2295.
55. [55] Chen, D., Song, M.Q., Liu, Y.J., et al. Inhibition of complement C3 might rescue vascular hyporeactivity in a conscious hemorrhagic shock rat model. Microvasc. Res. 105 (2015), 23–29.
56. [56] Cai, C., Gill, R., Eum, H.A., et al. Complement factor 3 deficiency attenuates hemorrhagic shock-related hepatic injury and systemic inflammatory response syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299 (2010), R1175–R1182.
57. [57] Goering, J., Pope, M.R., Fleming, S.D., TLR2 regulates complement-mediated inflammation induced by blood loss during hemorrhage. Shock 45 (2016), 33–39.
58. [58] Szebeni, J., Baranyi, L., Savay, S., et al. Complement activation during hemorrhagic shock and resuscitation in swine. Shock 20 (2003), 347–355.
59. [59] Dalle Lucca, J.J., Li, Y., Simovic, M., et al. Effects of C1 inhibitor on tissue damage in a porcine model of controlled hemorrhage. Shock 38 (2012), 82–91.
60. [60] Dalle Lucca, J.J., Simovic, M., Li, Y., et al. Decay-accelerating factor mitigates controlled hemorrhage-instigated intestinal and lung tissue damage and hyperkalemia in swine. J. Trauma 71 (2011), S151–S160.
61. [61] Fleming, S.D., Phillips, L.M., Lambris, J.D., Tsokos, G.C., Complement component C5a mediates hemorrhage-induced intestinal damage. J. Surg. Res. 150 (2008), 196–203.
62. [62] Peckham, R.M., Handrigan, M.T., Bentley, T.B., et al. C5-blocking antibody reduces fluid requirements and improves responsiveness to fluid infusion in hemorrhagic shock managed with hypotensive resuscitation. J. Appl. Physiol. (1985) 102 (2007), 673–680.
63. [63] Melis, J.P., Strumane, K., Ruuls, S.R., et al. Complement in therapy and disease: regulating the complement system with antibody-based therapeutics. Mol. Immunol. 67 (2015), 117–130.
64. [64] Ricklin, D., Lambris, J.D., Progress and trends in complement therapeutics. Adv. Exp. Med. Biol. 735 (2013), 1–22.
65. [65] Ward, P.A., Guo, R.F., Riedemann, N.C., Manipulation of the complement system for benefit in sepsis. Crit. Care Res. Pract., 2012, 2012, 427607.
66. [66] Silasi-Mansat, R., Zhu, H., Popescu, N.I., et al. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood 116 (2010), 1002–1010.
67. [67] Keshari, R., Silasi-Mansat, R., Popescu, N.I., Chaaban, H., Lupu, C., DeMarco, S.J., Florea, Lupu, A novel C5 complement inhibitor protects against sepsis-Induced activation of complement, coagulation and inflammation and provides survival benefit in E. coli sepsis. Blood(21), 2014 (Abstract at ASH meeting).
68. [68] Buras, J.A., Rice, L., Orlow, D., et al. Inhibition of C5 or absence of C6 protects from sepsis mortality. Immunobiology 209 (2004), 629–635.
69. [69] Hopken, U.E., Lu, B., Gerard, N.P., Gerard, C., The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383 (1996), 86–89.
70. [70] Stevens, J.H., O'Hanley, P., Shapiro, J.M., et al. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J. Clin. Invest. 77 (1986), 1812–1816.
71. [71] Hangen, D.H., Stevens, J.H., Satoh, P.S., et al. Complement levels in septic primates treated with anti-C5a antibodies. J. Surg. Res. 46 (1989), 195–199.
72. [72] Barratt-Due, A., Thorgersen, E.B., Egge, K., et al. Combined inhibition of complement (C5) and CD14 markedly attenuates inflammation, thrombogenicity, and hemodynamic changes in porcine sepsis. J. Immunol. 191:2 (2013), 819–827.
73. [73] Rittirsch, D., Flierl, M.A., Nadeau, B.A., et al. Functional roles for C5a receptors in sepsis. Nat. Med. 14 (2008), 551–557.
74. [74] Flierl, M.A., Rittirsch, D., Nadeau, B.A., et al. Functions of the complement components C3 and C5 during sepsis. FASEB J. 22 (2008), 3483–3490.
75. [75] Hoehlig, K., Maasch, C., Shushakova, N., et al. A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis. Mol. Ther. 21 (2013), 2236–2246.
76. [76] Giannoudi, M., Harwood, P., Damage control resuscitation: lessons learned. Eur. J. Trauma Emerg. Surg., 2016 Epub ahead of print.
77. [77] Mastellos, D.C., Deangelis, R.A., Lambris, J.D., Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis. Semin. Immunol. 25 (2013), 29–38.
78. [78] Zilow, G., Sturm, J.A., Rother, U., Kirschfink, M., Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clin. Exp. Immunol. 79 (1990), 151–157.
79. [79] Rich, M.C., Keene, C.N., Neher, M.D., et al. Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains. Neurosci. Lett. 617 (2016), 188–194.
80. [80] Schmidt, C.Q., Bai, H., Lin, Z., et al. Rational engineering of a minimized immune inhibitor with unique triple-targeting properties. J. Immunol. 190 (2013), 5712–5721.
81. [81] Schraufstatter, I.U., Trieu, K., Sikora, L., Sriramarao, P., DiScipio, R., Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J. Immunol. 169 (2002), 2102–2110.
82. [82] Fishelson, Z., Attali, G., Mevorach, D., Complement and apoptosis. Mol. Immunol. 38 (2001), 207–219.